A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1
Clinical trial NCT04223804 · COMPLETED
Trial details
- NCT number
- NCT04223804
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-30
- Primary completion
- 2023-02-27
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.